Vivek M Rangnekar

This inventor holds 4 USPTO granted patents and 5 published patent applications. Top assignee: University of Kentucky Research Foundation. Active years: 2010-2023.

USPTO Granted Patents = 4 (Patent Applications = 5)

% Patents Active = 100.0

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 4(Granted Patents)

Location History:

Lexington, KY (US) (2010 - 2019)
Nicholasville, KY (US) (2018 - 2023)

Company Filing History:

4 out of 903

University of Kentucky Research Foundation

patents

Years Active: 2010-2023

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11730750 - Drugs for GRP78 cell surface translocation and Par-4 secretion (2023-08-22),

2. 10512641 - Chloroquine induction par-4 and treatment of cancer (2019-12-24),

3. 9873670 - Arylquinoline and analog compounds and use thereof to treat cancer (2018-01-23),

4. 7786275 - Identification of a unique core domain of Par-4 sufficient for selective apoptosis induction in cancer cells (2010-08-31),

Title: Vivek M Rangnekar: Innovator in Cancer Treatment

Introduction

Vivek M Rangnekar is a prominent inventor based in Lexington, KY (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 4 patents, Rangnekar is recognized for his groundbreaking work in developing methods that enhance cancer therapies.

Latest Patents

Rangnekar's latest patents focus on novel approaches to cancer treatment. One of his notable inventions is a method for treating cancer that involves administering a pharmaceutically effective amount of two active agents. The first agent promotes the secretion of prostate apoptosis response-4 (Par-4) from normal cells, while the second agent elevates GRP78 receptors for Par-4 on the surface of cancer cells. Another significant patent describes methods for treating cancer by administering chloroquine, which induces Par-4 production in non-cancerous host cells, thereby promoting apoptosis in cancer cells, including androgen-insensitive prostate cancer cells.

Career Highlights

Rangnekar is affiliated with the University of Kentucky Research Foundation, where he continues to advance his research in cancer therapies. His work has garnered attention for its potential to improve treatment outcomes for cancer patients.

Collaborations

Some of Rangnekar's notable coworkers include David S Watt and Ravshan Burikhanov, who contribute to his research efforts and collaborative projects.

Conclusion

Vivek M Rangnekar is a dedicated inventor whose work in cancer treatment showcases his commitment to innovation and improving patient care. His patents reflect a deep understanding of cancer biology and a drive to develop effective therapeutic strategies.